Gsk (GSK) Non Operating Income (2010 - 2021)

Gsk (GSK) has 6 years of Non Operating Income data on file, last reported at $1.0 billion in Q4 2021.

• For the quarter ending Q4 2021, Non Operating Income changed N/A year-over-year to $1.0 billion; the trailing twelve-month figure through Dec 2021 stood at $661.7 million (changed N/A YoY), and the FY2023 full-year result was $842.1 million, down 15.27% from the prior year.
• Non Operating Income was $1.0 billion for Q4 2021 at Gsk, up from -$124.1 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $1.0 billion in Q4 2021 to a low of -$128.6 million in Q2 2021.